Avs Med Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.64 Cr
- Revenue Growth 0.08%
- Profit Growth 27.58%
- Ebitda 17.10%
- Net Worth 22.60%
- Total Assets 251.71%
About Avs Med Laboratories
Avs Med Laboratories Private Limited (AMLPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 December 2017 (Seven years and two months 10 days old ). Its registered office is in Chandauli, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.64 Cr.
Arvind Yadav and Manish Singh serve as directors at the Company.
Company Details
-
Location
Chandauli, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999UP2017PTC099145
-
Company No.
099145
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Dec 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Avs Med Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Yadav
|
Director | 06-Dec-2017 | Current |
|
Manish Singh
|
Director Appointed In Casual Vacancy | 06-Oct-2023 | Current |
Financial Performance of Avs Med Laboratories.
Avs Med Laboratories Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 0.08% increase. The company also saw a substantial improvement in profitability, with a 27.58% increase in profit. The company's net worth Soared by an impressive increase of 22.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avs Med Laboratories?
In 2018, Avs Med Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹26.40 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.69 Cr
- Canara Bank : 0.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Oct 2024 | Others | ₹1.69 Cr | Open |
| 20 Sep 2022 | Canara Bank | ₹9.50 M | Open |
How Many Employees Work at Avs Med Laboratories?
Unlock and access historical data on people associated with Avs Med Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avs Med Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avs Med Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
